Cornea/External Disease News

The top Healio blogs in ophthalmology last year explored the future of drug prices in the wake of the Inflation Reduction Act and important tips for avoiding Stark Law violations.

NEW YORK — In a presentation at OSN New York, Kourtney Houser, MD, discussed the importance of optimizing the cornea before premium cataract surgery.

Harrow announced three partnerships to support the upcoming launch of Vevye, indicated for treating the signs and symptoms of dry eye disease.

A pre-Descemet’s endothelial keratoplasty graft has numerous advantages over a Descemet’s membrane endothelial keratoplasty graft.

The top Healio cornea-related articles in 2023 included the FDA approval of Vevye for dry eye disease and the efficacy of azithromycin in the treatment of meibomian gland dysfunction.

The FDA granted orphan drug designation for Cellusion’s CLS001, a corneal endothelial cell substitute for bullous keratopathy, according to a press release.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Ashvin Agarwal, MD, overviews his video on traumatic iridodialysis repair.

There has certainly been a whole bunch of new stuff around the dry eye disease ranch, hasn’t there?

Nordic Pharma has acquired Visant Medical through its subsidiary Amring Pharmaceuticals.

Oculis has announced the first patient first visit in its phase 2b RELIEF trial evaluating licaminlimab, the company’s novel anti-tumor necrosis factor-alpha biologic eye drop, for treatment of moderate to severe dry eye disease.